In this study, we demonstrated that UTMD-mediated cardiac delivery of melatonin-related receptor genes could optimize the cardioprotective effects of a clinically safe dose of melatonin on sepsis-induced cardiomyopathy. This evidence concerns the gene GPR50 and Sepsis.